Emerson Reports Third Quarter 2024 Results; Updates 2024 Outlook

ST. LOUIS (August 7, 2024) - Emerson (NYSE: EMR) today reported results1 for its third quarter ended June 30, 2024 and updated its full year outlook for fiscal 2024. Emerson also declared a quarterly cash dividend of $0.525 per share of common stock payable September 10, 2024 to stockholders of record on August 16, 2024. 

Read More...
Click to continue reading

 

(dollars in millions, except per share)

2023 Q3

2024 Q3

Change

Underlying Orders2

3%

Net Sales

     Underlying Sales3

$3,946


$4,380


11%

3%

Pretax Earnings

     Margin

$822

20.8%

$455

10.4%


(1040) bps

Adjusted Segment EBITA4

     Margin

$1,060

26.9%

$1,189

27.1%


20 bps

GAAP Earnings Per Share

Adjusted Earnings Per Share5

$1.12

$1.29

$0.60

$1.43

(46)%

11%

Operating Cash Flow

Free Cash Flow

$842

$769

$1,067

$975

27%

27%

 Management Commentary

“Emerson delivered another strong quarter, with solid underlying orders growth and with profitability and cash flow both exceeding expectations,” said Emerson President and Chief Executive Officer Lal Karsanbhai. “Demand in process and hybrid markets, led by a constructive capex cycle, continues to meet expectations. Our operating leverage performance demonstrates the benefits of our highly differentiated technology and world-class Emerson Management System, giving us the confidence to execute on our plan for 2024." 

Karsanbhai continued, “In the quarter, we also took another important step to simplify our portfolio and enhance our focus as a global leader in automation with the definitive agreement to completely exit the Copeland business. Emerson is creating value for our shareholders as we execute with our higher growth and higher margin automation portfolio.”

2024 Outlook
The following tables summarize the fiscal year 2024 guidance framework for continuing operations6. The 2024 outlook assumes approximately $300 million returned to shareholders through share repurchases and approximately $1.2 billion of dividend payments. Guidance figures are approximate. 

2024

Net Sales Growth
Underlying Sales Growth

~15%
~6%

Earnings Per Share

     Amortization of Intangibles
     Restructuring and Related Costs
     Loss on Copeland Note Receivable
     Amortization of Acquisition-related Inventory Step-up
     Acquisition / Divestiture Fees and Related Costs
     Divestiture Loss / (Gain), net
     Discrete Tax Benefits

Adjusted Earnings Per Share

$2.82 - $2.87

~$1.42
~$0.34
$0.38
$0.38
~$0.24
($0.03)
($0.10)

$5.45 - $5.50

Operating Cash Flow
Free Cash Flow

~$3.2B
~$2.8B

  Notes:

Results are presented on a continuing operations basis.

Underlying orders does not include AspenTech.

3 Underlying sales excludes the impact of currency translation, and significant acquisitions and divestitures.

4 Adjusted segment EBITA represents segment earnings less restructuring and intangibles amortization expense.

5 Adjusted EPS excludes intangibles amortization expense, restructuring and related costs, the amortization of acquisition-related inventory step-up, acquisition/divestiture gains, losses, fees and related costs, discrete tax benefits, an AspenTech Micromine purchase price hedge and write-offs associated with Emerson's Russia exit.

With the June 6, 2024 definitive agreement to completely exit its remaining interests in the Copeland joint venture, Emerson will report financial results for the Copeland equity ownership as discontinued operations for all periods presented, beginning in Q3 2024. The earnings from discontinued operations for 2024 are expected to be $0.55 to $0.60 per share, including the after-tax gain on the equity stake in Copeland. The Copeland Note Receivable interest income through June 6, 2024 remains in continuing operations. The pretax loss on the sale of the note receivable, $279M ($217M after-tax), is also reported in continuing operations but excluded from adjusted earnings per share, ($0.38). 

Copeland Transaction Update 
As of August 2, 2024, Emerson has completed the previously announced sale of the Copeland Note Receivable to Copeland with pretax cash proceeds of $1.9 billion. The sale of the 40% equity stake to private equity funds managed by Blackstone, with pretax cash proceeds of $1.5 billion, is expected to close by the end of August. Emerson intends to use the approximately $2.9 billion after-tax cash proceeds from both transactions to pay down its existing debt obligations. Both transactions are expected to result in a net pretax gain of approximately $0.2 billion. 

Conference Call
Today, beginning at 8:00 a.m. Central Time / 9:00 a.m. Eastern Time, Emerson management will discuss the third quarter results during an investor conference call. Participants can access a live webcast available at www.emerson.com/investors at the time of the call. A replay of the call will be available for 90 days. Conference call slides will be posted in advance of the call on the company website.

About Emerson
Emerson (NYSE: EMR) is a global technology and software company providing innovative solutions for the world's essential industries. Through its leading automation portfolio, including its majority stake in AspenTech, Emerson helps hybrid, process and discrete manufacturers optimize operations, protect personnel, reduce emissions and achieve their sustainability goals. For more information, visit Emerson.com.    

Forward-Looking and Cautionary Statements
Statements in this press release that are not strictly historical may be “forward-looking” statements, which involve risks and uncertainties, and Emerson undertakes no obligation to update any such statements to reflect later developments. These risks and uncertainties include the scope, duration and ultimate impacts of the Russia-Ukraine and other global conflicts, as well as economic and currency conditions, market demand, pricing, protection of intellectual property, cybersecurity, tariffs, competitive and technological factors, inflation, among others, as set forth in the Company's most recent Annual Report on Form 10-K and subsequent reports filed with the SEC. The outlook contained herein represents the Company's expectation for its consolidated results, other than as noted herein. 

Emerson uses our Investor Relations website, www.Emerson.com/investors, as a means of disclosing information which may be of interest or material to our investors and for complying with disclosure obligations under Regulation FD. Accordingly, investors should monitor our Investor Relations website, in addition to following our press releases, SEC filings, public conference calls, webcasts and social media. The information contained on, or that may be accessed through, our website is not incorporated by reference into, and is not a part of, this document.

Contacts
Investors
Colleen Mettler
314-553-2197

Media 
Joseph Sala / Greg Klassen
Joele Frank, Wilkinson Brimmer Katcher
212-355-4449

Latest News

Emerson Ventures Invests in Symmera

Emerson today announced it has made a strategic investment through its corporate venture capital arm Emerson Ventures in Symmera, an early-stage...

Emerson Ventures Invests in First Resonance

Strategic investment from Emerson’s corporate venture capital arm supports First Resonance's ION Factory Operating System

Emerson Ventures Makes Strategic Investment in Spearix

Emerson has made a strategic investment through Emerson Ventures, its corporate venture capital arm, in Spearix Technologies, Inc., whose...
Please enable JavaScript to use this website.